WallStreetZenWallStreetZen

NASDAQ: EXEL
Exelixis Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for EXEL

Based on 6 analysts offering 12 month price targets for Exelixis Inc.
Min Forecast
$25.00+6.25%
Avg Forecast
$27.17+15.46%
Max Forecast
$31.00+31.75%

Should I buy or sell EXEL stock?

Based on 6 analysts offering ratings for Exelixis Inc.
Buy
Strong Buy
2 analysts 33.33%
Buy
2 analysts 33.33%
Hold
2 analysts 33.33%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their EXEL stock forecasts and price targets.

EXEL stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-11
lockedlocked$00.00+00.00%2024-04-10
lockedlocked$00.00+00.00%2024-02-07
lockedlocked$00.00+00.00%2024-02-02
lockedlocked$00.00+00.00%2023-12-19
Citigroup
Bottom 10%
10
Strong BuyInitiates Coverage On$31.00+31.75%2023-12-15
Morgan Stanley
HoldMaintains$23.00-2.25%2023-11-02

1 of 1

Forecast return on equity

Is EXEL forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.16%

Forecast return on assets

Is EXEL forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

EXEL revenue forecast

What is EXEL's revenue in the next 3 years based on estimates from 10 analysts?
Avg 1 year Forecast
$1.9B+4.27%
Avg 2 year Forecast
$2.1B+14.24%
Avg 3 year Forecast
$2.3B+28.07%
EXEL's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

EXEL earnings growth forecast

How is EXEL forecast to perform vs Biotechnology companies and vs the US market?
Company
55.63%
Industry
7.17%
Market
21.46%
EXEL's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
EXEL's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
EXEL's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

EXEL revenue growth forecast

How is EXEL forecast to perform vs Biotechnology companies and vs the US market?
Company
8.37%
Industry
37.04%
Market
9.92%
EXEL's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
EXEL's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

EXEL vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
EXEL$23.53$27.17+15.46%Buy
JAZZ$107.43$193.09+79.74%Strong Buy
VKTX$68.86$112.25+63.01%Strong Buy
CYTK$64.80$87.36+34.82%Strong Buy
CERE$42.07$44.13+4.88%Hold
View Top Biotech Stocks

Exelixis Stock Forecast FAQ

Is Exelixis Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 6 Wall Street analysts covering (NASDAQ: EXEL) stock is to Buy EXEL stock.

Out of 6 analysts, 2 (33.33%) are recommending EXEL as a Strong Buy, 2 (33.33%) are recommending EXEL as a Buy, 2 (33.33%) are recommending EXEL as a Hold, 0 (0%) are recommending EXEL as a Sell, and 0 (0%) are recommending EXEL as a Strong Sell.

If you're new to stock investing, here's how to buy Exelixis stock.

What is EXEL's revenue growth forecast for 2024-2026?

(NASDAQ: EXEL) Exelixis's forecast annual revenue growth rate of 8.37% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.04%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.92%.

Exelixis's revenue in 2024 is $1,830,208,000.On average, 10 Wall Street analysts forecast EXEL's revenue for 2024 to be $578,629,567,617, with the lowest EXEL revenue forecast at $560,075,594,938, and the highest EXEL revenue forecast at $592,041,365,664. On average, 9 Wall Street analysts forecast EXEL's revenue for 2025 to be $633,912,492,832, with the lowest EXEL revenue forecast at $599,563,615,230, and the highest EXEL revenue forecast at $687,947,773,671.

In 2026, EXEL is forecast to generate $710,686,433,513 in revenue, with the lowest revenue forecast at $628,154,833,854 and the highest revenue forecast at $794,835,877,739.

What is EXEL's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: EXEL) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is EXEL's Price Target?

According to 6 Wall Street analysts that have issued a 1 year EXEL price target, the average EXEL price target is $27.17, with the highest EXEL stock price forecast at $31.00 and the lowest EXEL stock price forecast at $25.00.

On average, Wall Street analysts predict that Exelixis's share price could reach $27.17 by Apr 11, 2025. The average Exelixis stock price prediction forecasts a potential upside of 15.46% from the current EXEL share price of $23.53.

What is EXEL's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: EXEL) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.